January 29, 2020 — North America’s medical devices industry saw a drop of 17.3% in overall deal activity during the fourth quarter of 2020, when compared to the four-quarter average, according to the healthcare market research firm GlobalData.
A total of 220 deals worth $16.93 billion were announced for the region during Q4 2020, against the last four-quarter average of 266 deals.
Of all the deal types, venture financing saw most activity in Q4 2020 with 127, representing a 57.7% share for the region.
In second place was mergers and acquisitions (M&A) with 70 deals, followed by private equity deals with 23 transactions, respectively capturing a 31.8% and 10.5% share of the overall deal activity for the quarter.
In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $11.94 billion, while private equity and venture financing deals totalled $2.69 and $2.31 billion, respectively.
Medical Devices Top Deals in Q4 2020
The top five medical devices deals accounted for 55.03% of the overall value during Q4 2020. The combined value of the top five medical devices deals stood at $9.32 billion, against the overall value of $16.93 billion recorded for the quarter.
The top five medical devices industry deals of Q4 2020 tracked by GlobalData were:
• Philips Healthcare’s $2.8 billion acquisition of BioTelemetry
• The $2.15 billion acquisition of Thrive Earlier Detection by Exact Sciences
• AdaptHealth’s $2 billion acquisition of AeroCare
• The $1.5 billion acquisition of point-of-care ultrasound (POCUS) vendor Butterfly Network by Longview Acquisition
• Casdin Capital and Rock Springs Capital Management’s private equity deal with Exact Sciences for $869.2 million.
For more information: www.globaldata.com/industries-we-cover/medical-devices
July 29, 2024 
